Status:

RECRUITING

Enhancing Engagement of Partners in Research

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Conditions:

Stakeholder Engagement

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to examine the implementation and effectiveness of a bundle of engagement strategies for pediatric patient centered outcomes research (PCOR) studies. The study aims to exa...

Eligibility Criteria

Inclusion

  • In order to be eligible to participate in this study, PIs must oversee a study that meets the following criteria:
  • Studies who either have not started enrollment or are within 1-3 months of the start of enrollment, and within the 25% ceiling for % recruitment target.
  • Studies that have started enrollment must be no further than 25% of projected enrollment timeline of the study (with at least 6 months remaining for enrollment).
  • Target n\>50 participants in study.
  • At least 10 stakeholder partners part of study. The PI's must also be ≥18 years old;
  • In order for study stakeholders to be eligible to participate in this study, an individual must meet all of the following criteria:
  • \>=12 years old;
  • Ability to speak either English, Spanish, or Chinese, and;
  • Part of the study team or serving in an advisory capacity to the study team
  • The same criteria as that used for stakeholder and PI eligibility applies to Key informant (KI) interviews.

Exclusion

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Not able to complete 6 month follow-up assessment
  • Children who are wards/foster children
  • Not able or willing to provide consent.
  • Concurrent enrollment in another study that is part of this research project.
  • In addition, PI's who meet the following criteria will be excluded from participation in this study:
  • 1\. A lot of experience with stakeholder engagement (based on screener survey question)

Key Trial Info

Start Date :

September 8 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

480 Patients enrolled

Trial Details

Trial ID

NCT07166913

Start Date

September 8 2025

End Date

December 1 2026

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016